Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
- PMID: 7490803
Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
Abstract
Purpose: We determined whether the sensitivity of detecting dysplasia or early bladder cancer can be improved by 5-aminolevulinic acid induced porphyrin fluorescence.
Materials and methods: A 3% 5-aminolevulinic acid solution was instilled intravesically before cystoscopy in 104 patients. The 5-aminolevulinic acid induced porphyrin fluorescence was excited by violet light from a krypton ion laser (wavelength 406.7 nm.).
Results: The sensitivity of the fluorescence cystoscopy (96.9%) was significantly (p < 0.0001) greater than that of white light cystoscopy (72.7%). There was no impact on specificity.
Conclusions: Due to the high sensitivity of the procedure fluorescence guided biopsies are recommended instead of random biopsies.
Comment in
-
Urothelial malignancy--much promise but little progress.J Urol. 1996 Jan;155(1):122. doi: 10.1016/s0022-5347(01)66565-0. J Urol. 1996. PMID: 7490807 No abstract available.
Similar articles
-
[ALA fluorescent diagnosis of bladder cancer].Urologiia. 2000 Sep-Oct;(5):48-50. Urologiia. 2000. PMID: 11392226 Russian.
-
Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.J Urol. 2005 Sep;174(3):862-6; discussion 866. doi: 10.1097/01.ju.0000169257.19841.2a. J Urol. 2005. PMID: 16093971 Clinical Trial.
-
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.Urology. 2007 Feb;69(2):260-4. doi: 10.1016/j.urology.2006.10.015. Urology. 2007. PMID: 17320660
-
Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?Curr Opin Urol. 2007 Sep;17(5):347-51. doi: 10.1097/MOU.0b013e3282c8c73f. Curr Opin Urol. 2007. PMID: 17762629 Review.
-
Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer.Expert Rev Anticancer Ther. 2009 Aug;9(8):1055-63. doi: 10.1586/era.09.73. Expert Rev Anticancer Ther. 2009. PMID: 19671025 Review.
Cited by
-
Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.Theranostics. 2012;2(9):916-66. doi: 10.7150/thno.4571. Epub 2012 Oct 4. Theranostics. 2012. PMID: 23082103 Free PMC article.
-
Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.BMJ Open. 2019 Oct 17;9(10):e028173. doi: 10.1136/bmjopen-2018-028173. BMJ Open. 2019. PMID: 31628123 Free PMC article.
-
Alterations of DNA methylome in human bladder cancer.Epigenetics. 2013 Oct;8(10):1013-22. doi: 10.4161/epi.25927. Epub 2013 Aug 6. Epigenetics. 2013. PMID: 23975266 Free PMC article. Review.
-
Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.Pharm Res. 1999 Feb;16(2):288-95. doi: 10.1023/a:1018840827910. Pharm Res. 1999. PMID: 10100316
-
Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.Br J Cancer. 1999 Mar;79(9-10):1603-8. doi: 10.1038/sj.bjc.6690255. Br J Cancer. 1999. PMID: 10188913 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical